SCHEMBL1937568

SCHEMBL1937568

CN1CCN(Cc2cccc(N)c2)C1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PKM P14618 1/20 0.44
DRD3 P35462 3/20 0.43
KCNH2 Q12809 3/20 0.43
DRD2 P14416 2/20 0.43
POLB P06746 3/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
ABHD6 Q9BV23 1/20 0.42
GRM2 Q14416 1/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13181440 0.83 KDM4E (0.48) KDM4EALDH1A1CYP3A4RECQLTDP1
SCHEMBL4177453 0.82 ADORA2A (0.51) KDM4EALDH1A1CYP3A4RECQLTDP1
SCHEMBL8916010 0.80 POLB (0.60) KDM4EALDH1A1CYP3A4RECQLTDP1
SCHEMBL13155342 0.79 DRD3 (0.50) KDM4EALDH1A1CYP3A4RECQLTDP1
SCHEMBL1937950 0.77 ALDH1A1 (0.54) KDM4EALDH1A1TDP1POLBKMT2A
SCHEMBL8924899 0.74 DRD3 (0.60) DRD3KCNH2POLBKMT2ACYP2D6
SCHEMBL2720932 0.74 L3MBTL1 (0.58) KMT2ACYP11B1CYP11B2
Hydrochloric Acid SCHEMBL6818484 0.73 L3MBTL1 (0.56) KMT2AMAOAMAOB
SCHEMBL2222171 0.73 L3MBTL1 (0.65) KMT2AGRM2SIGMAR1
SCHEMBL4055380 0.72 L3MBTL1 (0.68) KMT2AGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines Bayer ScienceCrop AG (DE) 2011-09-22 US disclosed
EP-2330904-A2 4-ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES Bayer CropScience AG (DE) 2011-06-15 EP disclosed
WO-2010025863-A2 4-ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines DPM1, DPYD, POLR1C KDM4E 1081/4885ALDH1A1 765/4885CYP3A4 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.